XML 60 R40.htm IDEA: XBRL DOCUMENT v3.24.1
Stockholders’ Equity (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Jan. 31, 2023
Dec. 31, 2018
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock issued for conversion of convertible debt, shares 2,380,996 839    
Accrued interest settled with common stock   $ 16,340    
Loss on settlement of convertible debt $ 477,221    
[custom:StockIssuedDuringPeriodSharesSettlementOfNotesPayable]   147,500    
Number of shares of common stock upon settlement of notes payable   $ 588,524    
Common stock vesting of restricted stock unit   27,989    
Common stock issued for cash, shares 1,607,044      
Common stock issued for cash   $ 10,008,095    
Number of shares of common stock issued for exercise of warrants   1,409,771    
Exercise of warrants, value   $ 14,098    
Common stock issued for exercise of warrants, shares   857,780    
Common stock issued for exercise of warrants notes payable, value   $ 576,476    
Number shares issued for conversion of note, shares   336,810    
Number shares issued for conversion dividends payable, shares   100,517    
Number of warrants to purchase     1,018,079  
Exercise price per share     $ 2.35  
Aggregate intrinsic value of warrants $ 0      
Number of shares vested under plan 480,325      
Restricted stock award granted value    
2018 Equity Incentive Plan [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock reserved for future issuance       3,000,000
Share granted under equity incentive plan 678,180      
Alto Convertible Note [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Number of warrants to purchase     71,266  
Exercise price per share     $ 2.35  
Restricted Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock issued for conversion of convertible debt, shares 85,195      
Restricted Stock Units (RSUs) [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Unrecognized compensation cost $ 231,550 $ 61,111    
Weighted Average Life (Years), Outstanding Ending 1 year 21 days 1 year 9 months 29 days    
Restricted Stock Units (RSUs) [Member] | Directors and Officers [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Restricted stock award granted shares 259,326 35,587    
Restricted stock award granted value $ 352,400 $ 100,000    
Common Stock [Member]        
Accumulated Other Comprehensive Income (Loss) [Line Items]        
Common stock issued for conversion of convertible debt, shares   148,339    
Debt, principal 1,925,700      
Accrued interest settled with common stock 294,927      
Loss on settlement of convertible debt $ 477,221      
Number of shares of common stock upon settlement of notes payable   $ 1    
Common stock issued for cash, shares 2,380,996 1,409,771    
Common stock issued for cash   $ 14    
Number of shares of common stock issued for exercise of warrants   1,409,771    
Exercise of warrants, value   $ 14    
Common stock issued for dividends payable   $ 402,068    
Restricted stock award granted shares 85,195 27,989    
Restricted stock award granted value $ 1